Ethanol-dependent induction of ultrastructural changes in the myocardium

Authors

Keywords:

myocardium, alcohol, ethanol, cardiomyocyte, apoptosis, fibrosis, fetal alcohol syndrome, alcoholic cardiomyopathy.

Abstract

Background. Since its inception, alcohol has been used throughout society, for rituals, worship, and because of its therapeutic, antibacterial, and analgesic properties. In moderation, alcohol consumption is generally considered clinically beneficial. On the other hand, it was recognized that excessive alcohol consumption by both men and women, especially during pregnancy or breastfeeding, has many negative consequences. Alcohol is a teratogenic factor, the prenatal effect of which can adversely affect the fetus, and with chronic use can lead to many diseases of the cardiovascular system. Global trends in increasing alcohol consumption by women of childbearing age are linked to economic development, changing gender roles, increasing access to alcohol, societal pressures, and social acceptance of alcohol use. As the rate of alcohol-related heart abnormalities is higher than previously thought, it is becoming increasingly important to understand the mechanisms behind them. Objective: to investigate the qualitative changes of heart tissue and the mechanisms of their occurrence, which are due to the prenatal and postnatal effects of ethanol, as well as to establish the relationship between alcohol consumption during pregnancy and the occurrence of FASD in the offspring, by means of a bibliographic analysis of the literature. Methods. Bibliographic analysis is based on published foreign articles, books, teaching aids, monographs, abstracts of dissertations. The search period of coverage is from 2012 to 2022, but the review includes some data from earlier publications, since these literary sources have significant scientific value. Results. Analysis of literary sources made it possible to form a clear idea of ​​the macro-, micro- and ultrastructural changes in the myocardium, which are observed in offspring born to alcoholized mothers. It was investigated that the prenatal effect of ethanol induces significant changes in the relative weight of the heart, wall thickness of the left ventricle and the size of cardiomyocytes. Chronic ethanol use induces myocytolysis, apoptosis and necrosis of cardiac cells with renewal mechanisms leading to hypertrophy and interstitial fibrosis. The constant influence of alcohol leads to dysfunction of sarcomeres and changes in the composition of cell membranes, receptors, ion channels, intracellular transitional Ca2 + processes and structural proteins. Heart remodeling is a compensatory mechanism for the above disorders in response to various aggressive factors. Conclusion. The alarmingly increasing incidence and prevalence of fetal alcohol syndrome is a public health problem that requires strategic and timely action for both pregnant women and women of reproductive age who consume alcohol and their offspring who may be at risk. Prevention initiatives to reduce alcohol consumption before and during pregnancy should be undertaken worldwide.

References

  1. Slade T, Chapman C, Swift W, Keyes K, Tonks Z, Teesson M. Birth cohort trends in the global epidemiology of alcohol use and alcohol-related harms in men and women: Systematic review and metaregression. BMJ Open. 2016;6:e011827.
  2. Denny CH, Acero CS, Terplan M, Kim SY. Trends in alcohol use among pregnant women in the USA. Am. J. Prev. Med. 2020;59:768–769.
  3. Geels LM, Vink JM, van Beek JHDA, Bartel Willemsen, Gs M, Boomsma DI. Increases in alcohol consumption in women and elderly groups: Evidence from an epidemiological study. BMC Public Health. 2013;13: 207.
  4. World Health Organization. Global Status Report on Alcohol and Health. World Health Organization: Geneva, Switzerland, 2018.
  5. Manthey J, Shield KD, Rylett M, Hasan OSM, Probst C, Rehm J. Global alcohol exposure between 1990 and 2017 and forecasts until 2030: A modelling study. Lancet. 2019;393:2493–2502.
  6. NANOS Research. COVID-19 and Increased Alcohol Consumption: Canadian Centre on Substance Use and Addiction. NANOS Poll Summary Report. 2020;1(2):35
  7. Naughton F, Ward E, Khondoker M, Belderson P, Marie Minihane A, Dainty J, Hanson S, Holland R, Brown T, Notley C. Health behaviour change during the UK COVID-19 lockdown: Findings from the first wave of the C-19 health behaviour and well-being daily tracker study. Br. J. Health Psychol. 2021;26:624–643.
  8. Pollard MS, Tucker JS, Green JHD. Changes in adult alcohol use and consequences during the COVID-19 pandemic in the US. JAMA Netw. 2020;3:e2022942.
  9. Sher J. Fetal alcohol spectrum disorders: Preventing collateral damage from COVID-19. Lancet Public Health. 2020;5:e424.
  10. Smith CL, Waters SF, Spellacy D, Burduli E, Brooks O, Carty CL, Ranjo S, McPherson S, Barbosa-Leiker C. Substance use and mental health in pregnant women during the COVID-19 pandemic. J. Reprod. Infant Psychol. 2021:1–14.
  11. Kar P, Tomfohr-Madsen L, Giesbrecht G, Bagshawe M, Lebel C. Alcohol and substance use in pregnancy during the COVID-19 pandemic. Drug Alcohol Depend. 2021;225:108760.
  12. Popova S, Lange S, Probst C, Gmel G, Rehm J. Global prevalence of alcohol use and binge drinking during pregnancy, and fetal alcohol spectrum disorder. Biochem. Cell Biol. 2018;96:237–240.
  13. Underwood MA, Gilbert WM, Sherman MP. Amniotic fluid: Not just fetal urine anymore. J. Perinatol. 2005;25:341–348.
  14. Kesmodel U, Wisborg K, Olsen SF, Henriksen TB, Secher NJ. Moderate alcohol intake during pregnancy and the risk of stillbirth and death in the first year of life. Am. J. Epidemiol. 2002;155:305–312.
  15. Henriksen TB, Hjollund NH, Jensen TK, Bonde JP, Andersson AM, Kolstad H, Ernst E, Giwercman A, Skakkebæk NE, Olsen J. Alcohol consumption at the time of conception and spontaneous abortion. Am. J. Epidemiol. 2004;160:661–667.
  16. Albertsen K, Andersen AMN, Olsen J, Grønbæk M. Alcohol consumption during pregnancy and the risk of preterm delivery. Am. J. Epidemiol. 2004; 159:155–161.
  17. Kesmodel U, Olsen SF, Secher NJ. Does alcohol increase the risk of preterm delivery? Epidemiology. 2000;2:512–518.
  18. Patra J, Bakker R, Irving H, Jaddoe VW, Malini S, Rehm J. Dose–response relationship between alcohol consumption before and during pregnancy and the risks of low birthweight, preterm birth and small for gestational age (SGA)—A systematic review and meta-analyses. BJOG Int.J. Obstet. Gynaecol. 2011;118:1411–1421.
  19. Yang Q, Witkiewicz BB, Olney RS, Liu Y, Davis M, Khoury MJ, Correa A, Erickson JD. A case-control study of maternal alcohol consumption and intrauterine growth retardation. Ann. Epidemiol. 2001;11:497–503.
  20. O’Callaghan FV, O’Callaghan M, Najman JM, Williams GM, Bor W. Maternal alcohol consumption during pregnancy and physical outcomes up to 5 years of age: A longitudinal study. Early Hum. Dev. 2003;71:137–148.
  21. Stratton KR, Howe CJ, Battaglia FC. Fetal Alcohol Syndrome: Diagnosis, Epidemiology, Prevention, and Treatment. National Academy Press: Washington, DC, USA. 1996.
  22. Hannigan JH, Abel EL. Animal models of fetal alcohol syndrome. In Alcohol, Pregnancy and the Developing Child. Cambridge University Press. 1996:77–102.
  23. Popova S, Lange S, Shield K, Mihic A, Chudley AE, Mukherjee RAS, Bekmuradov D, Rehm J. Comorbidity of fetal alcohol spectrum disorder: A systematic review and meta-analysis. Lancet. 2016;387:978–987.
  24. Jégou S, El Ghazi F, de Lendeu PK, Marret S, Laudenbach V, Uguen A, Marcorelles P, Roy V, Laquerrière A, Gonzalez BJ. Prenatal alcohol exposure affects vasculature development in the neonatal brain. Ann. Neurol. 2012;72:952–960.
  25. Cartwright MM, Smith SM. Increased cell death and reduced neural crest cell numbers in ethanol-exposed Embryos: Partial basis for the fetal alcohol syndrome phenotype. Alcohol. Clin. Exp. Res. 1995;19:378–386.
  26. Vangipuram SD, Grever WE, Parker GC, Lyman WD. Ethanol increases fetal human neurosphere size and alters adhesion molecule gene expression. Alcohol. Clin. Exp. Res. 2008;32:339–347.
  27. Pruett D, Waterman EH, Caughey AB. Fetal alcohol exposure: consequences, diagnosis, and treatment. Obstet Gynecol Surv. 2013;68:62–69.
  28. Zhou FC, Zhao Q, Liu Y, Goodlett CR, Liang T, McClintick JN. Alteration of gene expression by alcohol exposure at early neurulation. BMC Genomics. 2011;12(1):124.
  29. Vallés S, Pitarch J, Renau-Piqueras J, Guerri C. Ethanol exposure affects glial fibrillary acidic protein gene expression and transcription during rat brain development. J Neurochem. 2002;69(6):2484–2493.
  30. Liesi P. Ethanol-exposed central neurons fail to migrate and undergo apoptosis. J Neurosci Res. 2020;48(5):439–448.
  31. GÓMEZ-ROIG, Dolores M. Environmental exposure during pregnancy: influence on prenatal development and early life: a comprehensive review. Fetal diagnosis and therapy. 2021;48(4):245-257.
  32. Kim AS, Miller EJ, Young LH. AMP-activated protein kinase: a core signalling pathway in the heart. Acta Physiol Oxf Engl. 2009;196(1):37–53.
  33. CONLON Steven. Teratogenic Effects of Prenatal Alcohol Exposure on Cardiac Innervation. Pediatrics. 2021;3(147):368-369.
  34. Rubin E. Alcoholic myopathy in heart and skeletal muscle. N Engl J Med. 1979;301:28–33.
  35. GUZZO-MERELLO, Gonzalo. Alcoholic cardiomyopathy. World journal of cardiology. 2014;6(8):771.
  36. Hibbs RG, Ferrans VJ, Black WC, Weilbaecher DG, Burch GE. Alcoholic cardiomyopathy; an electron microscopic study. Am Heart J. 1965;69:766–779.
  37. Rodrigues P, Santos-Ribeiro S, Teodoro T, Gomes FV, Leal I, Reis JP, Goff DC, Gonçalves A, Lima JAC. Association Between Alcohol Intake and Cardiac Remodeling. J. Am. Coll. Cardiol. 2018;72:1452–1462.
  38. Iacovoni A, De Maria R, Gavazzi A. Alcoholic cardiomyopathy. J. Cardiovasc. Med. 2010;11:884–892.
  39. Li X, Nie Y, Lian H, Hu S. Histopathologic features of alcoholic cardiomyopathy compared with idiopathic dilated cardiomyopathy. Go Med. 2018;97:e12259.
  40. Urbano-Márquez A, Fernández-Solà J. Effects of alcohol on skeletal and cardiac muscle. Muscle Nerve. 2004;30:689–707.
  41. Guzzo-Merello G, Segovia J, Domínguez F, Cobo-Marcos M, Gómez-Bueno M, Avellana P, Millán I, Alonso-Pulpón L, García-Pavía P. Natural history and prognostic factors in alcoholic cardiomyopathy. JACC Heart Fail. 2015;3:78–86
  42. Fernández-Solà J. The effects of ethanol on the heart: alcoholic cardiomyopathy. Nutrients. 2020;12(2):572.
  43. Piano MR. Alcohol's effects on the cardiovascular system. Alcohol Res. 2017;38:219–241.
  44. Mirijello A, Tarli C, Vassallo GA, Sestito L, Antonelli M, d'Angelo C. Alcoholic cardiomyopathy: what is known and what is not known. Eur J Intern Med. 2017;43:1–5.
  45. DAY Ed RUDD, James HF. Alcohol use disorders and the heart. Addiction. 2019;114(9):1670-1678.
  46. Steiner, Jennifer L, Lang Charles H. Etiology of alcoholic cardiomyopathy: mitochondria, oxidative stress and apoptosis. The International Journal of Biochemistry & Cell Biology. 2017;S1357272517301450–. doi:10.1016/j.biocel.2017.06.009
  47. Laurent D, Mathew JE, Mitry M, Taft M, Force A, Edwards JG. Chronic ethanol consumption increases myocardial mitochondrial DNA mutations: a potential contribution by mitochondrial topoisomerases. Alcohol Alcohol. 2014;49(4):381-389. doi: 10.1093/alcalc/agu029. PubMed PMID: 24852753; PubMed Central PMCID: PMCPMC4060737.
  48. Wang Y, Li Z, Zhang Y, Yang W, Sun J, Shan L. Targeting Pin1 Protects Mouse Cardiomyocytes from High-Dose Alcohol-Induced Apoptosis. Oxid Med Cell Longev. 2016;2016:4528906. doi: 10.1155/2016/4528906. PubMed PMID: 26697133; PubMed Central PMCID: PMCPMC4678095.
  49. Wang Y, Zhao J, Yang W, Bi Y, Chi J, Tian J. High-dose alcohol induces reactive oxygen speciesmediated apoptosis via PKC-β/p66Shc in mouse primary cardiomyocytes. Biochem Biophys Res Commun. 2015;456(2):656-61. doi: 10.1016/j.bbrc.2014.12.012. PubMed PMID: 25499814.
  50. Segel LD, Rendig SV, Choquet Y, Chacko K, Amsterdam EA, Mason DT. Effects of chronic graded ethanol consumption on the metabolism, ultrastructure, and mechanical function of the rat heart. Cardiovasc Res. 1975;9(5):649-663. PubMed PMID: 127656.
  51. Aberle N. Experimental Assessment of the Role of Acetaldehyde in Alcoholic Cardiomyopathy. Biol. Proced. 2003; 5:1–12.
  52. Oliveira G, Beezer AE, Hadgraft J, Lane ME. Alcohol enhanced permeation in model membranes. Part I. Thermodynamic and kinetic analyses of membrane permeation. Int. J. Pharm. 2010;393:61–67. doi: 10.1016/j.ijpharm.2010.03.062.
  53. Fernández-Solà J. Cardiovascular risks and benefits of moderate and heavy alcohol consumption. Nat. Rev. Cardiol. 2015;12:576–587. doi: 10.1038/nrcardio.2015.91.
  54. Noritake K, Aki T, Funakoshi T, Unuma K, Uemura K. Direct Exposure to Ethanol Disrupts Junctional Cell-Cell Contact and Hippo-YAP Signaling in HL-1 Murine Atrial Cardiomyocytes. PLos ONE. 2015;10:e0136952. doi: 10.1371/journal.pone.0136952.
  55. Fernández-Solà J. The Effects of Ethanol on the Heart: Alcoholic Cardiomyopathy. Nutrients. 2020;12(2), 572. https://doi.org/10.3390/nu12020572
  56. Agarwal DP. Genetic polymorphisms of alcohol metabolizing enzymes. Pathol. Biol. 2001;49:703–709.
  57. Ren J, Wold LE. Mechanisms of alcoholic heart disease. Adv. Cardiovasc. Dis. 2008;2:497–506.
  58. Aberle NS, Ren J. Experimental Assessment of the Role of Acetaldehyde in Alcoholic Cardiomyopathy. Biol. Proced. 2003;5:1–12.
  59. Oba T, Maeno Y, Ishida K. Differential contribution of clinical amounts of acetaldehyde to skeletal and cardiac muscle dysfunction in alcoholic myopathy. Curr. Pharm Des. 2005;11:791–800.
  60. Leibing E, Meyer T. Enzymes and signal pathways in the pathogenesis of alcoholic cardiomyopathy. Herz. 2016;41:478–483.

Downloads

Published

2022-09-26

How to Cite

Cherkas , O., & Marchenko, D. (2022). Ethanol-dependent induction of ultrastructural changes in the myocardium. Морфологія / Morphologia / Morfologìâ, 16(3), 15–22. Retrieved from https://morphology.dma.edu.ua/article/view/281888

Issue

Vol. 16 No. 3 (2022)

Section

Статті

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

 The authors reserve the right to authorship of their work and transfer to the Journal the right to the first publication of this work under the terms of a license Creative commons Attribution 4.0 International (CC BY 4.0), which allows other people to freely distribute the published work with a mandatory reference to the authors of the original work and the first publication of the work in this journal.
        By submitting a manuscript to the editorial office of the Journal ‘Morphologia’ authors agree to transfer the rights to protect and use the manuscript (all supplemental materials, particularly protected objects such as photos, drawings, diagrams, tables, etc.), including the reproduction in the press and distribution via the Internet; translation of the manuscript into any language; export and import of journal copies with the Authors’ article in order to make it available for public. Authors convey the rights mentioned above to the editorial office without any temporal or territorial limitation all over the world. 
        The Authors guarantee that they have the exclusive rights to use the material transferred to editorial office. Editors are not responsible to third parties for contraventions of warranty given by the Authors. The considered rights are transferred to the editorial office since the moment when the current issue is signed for publishing. Reproduction of materials published in the Journal by other individuals and legal entities is possible only with the consent of Editorial office, with the obligatory indication of the full bibliographic reference of the primary publication. The Authors reserve the right to use the published material, its fragments and parts for teaching materials, oral presentations, dissertation thesis prepararion with obligatory bibliographic citation of the original paper. Electron copy of the published article, downloaded from official journal web-site in .pdf format may be put by authors on the official web-site of their institutions, any other official resources with open access.